My model for improving access to medicines for chronic patients is Medicineconnect.Medicineconnect is a mobile application (App) which will enable patients to register as users and motorists drivers to register as providers. The App will enable providers to be able to collect chronic medicines for clients in their clinics or remote automation dispensing units (RADU) and deliver the parcels to the patient without the patient having to visit the healthcare facility. The model will always locate a provider from the patients' area who is near the healthcare facility at the time of initiating the collection of the medicine. In the process the provider will charge a fee less than the traveling cost for patient to collect their medicines on their own. Medicineconnect aims to improve access to medicines and eliminate the traveling and days of queuing for merely collecting chronic medicines. The Application will grant third-party to collect medicine on behalf of patients and drop the medicines at their homes. In addition the App will enable the patient to remotely view the availability of their medicines at their healthcare facility before they can initiate a pick-up. Medicineconnect is a mobile application (App) which allows patients to register as users and drivers of (vehicles and motorcycles) to register as providers. In addition to access to medicine function the App will be utilize to educate patients on disease management and this function will be managed by the pharmacist responsible for patient education. Patients will be updated regularly about their disease and therapeutics use, in text, videos and pictogram format. The patient education will be individualized and focused, but it will also include education on other health risks factor that exist in the communities. Furthermore, it will be used as a platform to initiate a community pharmacovigilance programme where patients will be capacitated to report adverse drug reactions online. Medicineconnect is a mobile application which connects patients with healthcare facilities (pharmacies, clinics and medical practice). Chronic patients will be registered on the application at the healthcare facilities (pharmacies, clinics and medical practice). The registration process will require demographic details of the patients and at the facility link the pharmacy; clinic dispensaries will link the patient medication through a bar-coding.Medicineconnect main-frame will collect data about patient demographics, conditions (ICD10) and motorist details in the different healthcare facilities and the information classify stratified according to the patients¡¯ treatment details and the date of collection. This data will be used to quantify number of patient served by programme and their disease categories. Medicineconnect will automatically send information of the next group of patients due for medication to the respective healthcare facility informing them to prepare the medicine packages and a list of registered Medicineconnectpers. A barcoding system will be utilized to allocate unique identifier for Medicineconnectpers. Medicineconnectpers will be extended to healthcare workers, because they live in communities where some of the chronic patients live. The data collected through the programme will be used assist pharmaceutical services to plan and budget for the following year of operation. The main function for Medicineconnect in the healthcare facility is to link the patient Medicineconnect profile with the patient therapeutic treatment. The dispensary in the different healthcare facilities will use barcode scanning to link the patient treatment. In addition to the scanner, the healthcare facilities will have Medicineconnect Booth outside the dispensaries to assist with opening profiles for patients and Medicineconnectpers. The application will also pre-allocate collection dates for the patient treatment dates and continuously alert the patients of their date for treatment. The scheduling function will only activate the patient collection date within the pre-allocated week. Outside these times, the patient cannot initiate a parcel pick-up. Further additional information will be pharmacovigilance function which allows patient to report adverse drug reactions (ADRs). The patient will be allowed to log a request to motorists, requesting the Medicineconnectper to collect the patient¡¯s chronic medicines from their healthcare facility. The application will triangulate and locate a registered motorist from the patient community who is at the time to the call is nearby the healthcare facilities. If the motorist accepts the Drop the application will send an electronic pick up note to the health facilities and a confirmatory message to the patient with an estimated delivery time. Medicineconnect¡¯s customer satisfaction function will be the centre of the programme and patients will be asked five simple questions: How was the service of the Medicineconnectper? Will you recommend the Medicineconnectper to your family and friends? Will you recommend Medicineconnect to other patients? Has Medicineconnect improved your access to your medicines? How can we improve our services? These five questions will be asked at the end of every service offered to the patient by a Medicineconnectper. The key function of Medicineconnectper is to pick-up chronic medicines for patients in healthcare facilities to deliver them to the patients. The Medicineconnectpers will be required to register to deliver within their community to not greater than five healthcare facilities. Medicineconnectpers will be vetted and issued with contracts of fee for service. Medicineconnectpers will only be transporting prepared patients parcels and not boxes of stock. Therefore a Medicineconnectper will be allowed to transport a certain number of parcels at a time. A GPS tracking system will be employed to track the position of the parcel at any point in time during its transportation. The model for the mobile technology users was inspired by the Uber systems which connects commuters with motorists and its scale able ability in countries where it exist shows the possibility of Medicineconnect's survival. This is also because more people use automobile to travel and smartphones to communicate and communities have some sort of transport system for commuters which can be contracted and linked to play a major role in increasing access to chronic medicines. These existing transport systems can act as coordinated logistics platforms for deliveries medicines to patients in deep rural areas, urban and to their place of work at a reasonable fee, which is less than what they will pay for traveling cost to healthcare facilities. The criteria for vehicles that can register to provide these services will be drafted and communicated with the relevant regulatory authorities for approval. However this should not be seen as an impediment to increasing access. The primary impact of medicineconnect is to increase access of chronic medicine to stable patients living with chronic disease. It also aims to reduce healthcare acquired infections (HAI) on patients living with chronic diseases and lastly reduce the cost of traveling to healthcare facilities only to collect medicine. In closure, patient will not be required to loss a day of work or income because they need to collect their chronic medicines.